Business Description
Fractyl Health Inc
NAICS : 541714
SIC : 2834
ISIN : US35168W1036
Description
Fractyl Health Inc is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including type 2 diabetes and obesity. The company focuses on transforming metabolic disease treatment from chronic symptomatic management to durable disease modifying therapies that target the organ level root causes of T2D and obesity.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.35 | |||||
| Equity-to-Asset | 0.4 | |||||
| Debt-to-Equity | 1.25 | |||||
| Debt-to-EBITDA | -0.78 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -4.43 | |||||
| Beneish M-Score | -3.14 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -45.9 | |||||
| 3-Year EPS without NRI Growth Rate | -70.7 | |||||
| 3-Year FCF Growth Rate | -34 | |||||
| 3-Year Book Growth Rate | -48.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.21 | |||||
| 9-Day RSI | 38.81 | |||||
| 14-Day RSI | 41.83 | |||||
| 3-1 Month Momentum % | -15.05 | |||||
| 6-1 Month Momentum % | -59.97 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.58 | |||||
| Quick Ratio | 5.57 | |||||
| Cash Ratio | 5.39 | |||||
| Days Inventory | 503.98 | |||||
| Days Sales Outstanding | 104.61 | |||||
| Days Payable | 8956.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 16.7 | |||||
| Shareholder Yield % | -126.31 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 46.39 | |||||
| Operating Margin % | -83816.5 | |||||
| Net Margin % | -64849.49 | |||||
| FCF Margin % | -62632.99 | |||||
| ROA % | -55.19 | |||||
| ROIC % | -216.49 | |||||
| 3-Year ROIIC % | -68.05 | |||||
| ROC (Joel Greenblatt) % | -319.25 | |||||
| ROCE % | -80.18 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1102.5 | |||||
| PB Ratio | 2.11 | |||||
| Price-to-Tangible-Book | 1.94 | |||||
| EV-to-EBIT | -1.08 | |||||
| EV-to-EBITDA | -1.09 | |||||
| EV-to-Revenue | 906.53 | |||||
| EV-to-FCF | -1.39 | |||||
| Price-to-Net-Current-Asset-Value | 8.87 | |||||
| Price-to-Net-Cash | 12 | |||||
| Earnings Yield (Greenblatt) % | -92.59 | |||||
| FCF Yield % | -57.28 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GUTS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fractyl Health Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.097 | ||
| EPS (TTM) ($) | -1.504 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 41.83 | ||
| 14-Day ATR ($) | 0.232268 | ||
| 20-Day SMA ($) | 2.237 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 1.74 - 14.5 | ||
| Shares Outstanding (Mil) | 48.1 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Fractyl Health Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Fractyl Health Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Fractyl Health Inc Frequently Asked Questions
What is Fractyl Health Inc(GUTS)'s stock price today?
The current price of GUTS is $2.04. The 52 week high of GUTS is $14.50 and 52 week low is $1.74.
When is next earnings date of Fractyl Health Inc(GUTS)?
The next earnings date of Fractyl Health Inc(GUTS) is 2025-02-28 Est..
Does Fractyl Health Inc(GUTS) pay dividends? If so, how much?
Fractyl Health Inc(GUTS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers